The largest database of trusted experimental protocols
> Procedures > Laboratory Procedure > Leukocyte Count

Leukocyte Count

Leukocyte Count: A quantitative assessment of the number of white blood cells (leukocytes) present in a sample of blood.
This measurement is commonly used to evaluate overall health, detect and monitor infections, and assess the body's immune response.
Accurately determining leukocyte count is crucial for a wide range of medical and research applications, including the diagnosis and management of hematological disorders, infectious diseases, and inflammatory conditions.
PubCompare.ai's AI-driven platform can help optimize your leukocyte count research by effortlessly locating the most relevant protocols from literature, pre-prints, and patents, enabling intelligent comparisons to identify the best protocols and products.
Unleash the power of PubCompare.ai to enhance your research reproducibility and accuracy, and take your leukocyte count studies to new heigths.

Most cited protocols related to «Leukocyte Count»

We performed two in silico experiments to assess the detection limits of different deconvolution algorithms. In the first experiment (Supplementary Fig. 6), we used the same cell line GEPs described above to compare CIBERSORT and RLR with five other GEP deconvolution methods4 (link)–8 (link). We evaluated detection limit using Jurkat cells (spike-in concentrations of 0.5%, 1%, 2.5%, 5%, 7.5%, and 10%), whose reference GEP (median of three replicates in GSE11103) was added into randomly created background mixtures of the other three blood cell lines. Five mixtures were created for each spike-in concentration. Predicted Jurkat fractions were assessed in the presence of differential tumor content, which we simulated by adding HCT116 (described above) in ten even increments, from 0% to 90%. Of note, we also used the same marker or signature genes described for simulated tumors (above). In a second experiment (Supplementary Fig. 7a), we compared CIBERSORT with QP5 (link), LLSR4 (link), PERT6 (link), and RLR. We spiked naïve B cell GEPs from the leukocyte signature matrix into four random background mixtures of the remaining 21 leukocyte subsets in the signature matrix. The same background mixtures were used for each spike-in. We also tested the addition of unknown content by adding defined proportions (0 to 90%) of randomly permuted expression values from a naïve B cell reference transcriptome (median expression profile from samples used to build LM22, Supplementary Table 1). We then repeated this analysis for each of the remaining leukocyte subsets in LM22 (Supplementary Fig. 7b).
Publication 2015
B-Lymphocytes BLOOD Cell Lines Cytosol Genes Jurkat Cells Leukocyte Count Leukocytes Neoplasms Transcriptome
The Metabochip was designed by representatives of the Body Fat Percentage [9] (link), CARDIoGRAM (coronary artery disease and myocardial infarction) [10] (link), DIAGRAM (type 2 diabetes) [11] (link), GIANT (anthropometric traits) [3] (link), [12] (link), [13] (link), Global Lipids Genetics (lipids) [4] (link), HaemGen (hematological measures) [14] (link), ICBP (blood pressure) [15] (link), MAGIC (glucose and insulin) [16] (link)–[18] (link), and QT-IGC (QT interval) [19] (link), [20] (link) GWAS meta-analysis consortia. The array is comprised of SNPs selected across two tiers of traits (Table 1). Tier 1 is comprised of eleven traits deemed to be of primary interest: type 2 diabetes (T2D), fasting glucose, coronary artery disease and myocardial infarction (CAD/MI), low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, body mass index (BMI), systolic and diastolic blood pressure, QT interval, and waist-to-hip ratio adjusted for BMI (WHR). Tier 2 is comprised of twelve traits of secondary interest: fasting insulin, 2-hour glucose, glycated hemoglobin (HbA1c), T2D age of diagnosis, early onset T2D (diagnosis age<45 years), waist circumference adjusted for BMI, height, body fat percentage, total cholesterol, platelet count, mean platelet volume, and white blood cell count.
We included three design classes of SNPs on the Metabochip (Table 2):
In total, 217,695 SNPs were chosen for the array (Table 2). 20,970 SNPs (9.6%) failed during the assay manufacturing process, resulting in 196,725 SNPs available for genotyping. A summary file annotating each Metabochip SNP with ascertainment criteria, SNP assay, a list of unintended duplicate SNPs (Supplementary Table S4), and reference strand orientation for alleles is provided at http://www.sph.umich.edu/csg/kang/MetaboChip/.
Full text: Click here
Publication 2012
ADCAD1 Alleles Biological Assay Blood Pressure Body Fat Cholesterol Diabetes Mellitus, Non-Insulin-Dependent Diagnosis Genome-Wide Association Study Gigantism Glucose Hemoglobin, Glycosylated High Density Lipoprotein Cholesterol Index, Body Mass Insulin Leukocyte Count Lipids Low-Density Lipoproteins Platelet Counts, Blood Pressure, Diastolic Single Nucleotide Polymorphism Systole Triglycerides Volumes, Mean Platelet Waist-Hip Ratio Waist Circumference
This study was a preplanned secondary analysis of a prospective registry of consecutive ED patients with severe sepsis with evidence of hypoperfusion treated with an institutional quantitative resuscitation protocol that is initiated in the ED at the time of recognition of sepsis (18 (link)). This study protocol was reviewed and approved by the institutional review board for the conduct of human research before enrollment of patients.
Subjects were enrolled from November 2005 through October 2007 in the ED at Carolinas Medical Center, an 800-bed teaching hospital with 120,000 ED patient visits per year. Explicit criteria for enrollment included 1) age >17 years; 2) suspected or confirmed infection; 3) two or more systemic inflammatory response syndrome criteria (19 (link)): heart rate >90 beats per minute, respiratory rate >20 breaths per minute, temperature >38°C or <36°C, white blood cell count >12,000 or <4000 cells/mm3 or >10% bands; and 4) systolic blood pressure <90 mm Hg or mean arterial pressure <65 mm Hg after a isotonic fluid bolus and anticipated need for ICU care, or a serum lactate concentration ≥4.0 mmol/L and anticipated need for ICU care. Exclusion criteria included 1) age <18 years; 2) need for immediate surgery; and 3) absolute contraindication for a chest central venous catheter.
Eligible subjects were identified by board-certified emergency physicians and were treated in the ED and medical ICU with an institution-approved quantitative resuscitation protocol that was previously described (20 (link)). All data elements required for calculation of the SOFA score at the time of ED recognition and resuscitation (T0) and 72 hours after ICU admission (T72), as well as hospital outcomes, were prospectively collected on standardized forms and entered into a database for later analysis. For T0 scores, only data available in the ED were used for calculation; and for T72 scores, data available within 12 hours of the 72-hour time point were used for calculation. To our knowledge, no physician in the ED had any independent knowledge of the SOFA score. For purposes of this study, we made one modification in the calculation of the respiratory component of the SOFA score (Table 1). We preferentially used the PaO2 to FIO2 ratio (PaO2/FIO2) when arterial blood gases were obtained. In cases where the PaO2 was not available, we used the peripheral arterial oxygen saturation (SaO2) to FIO2 ratio (SaO2/FIO2). This substitution has been previously validated with high correlation (21 (link)). The definitions of SOFA score variables were otherwise identical to those reported in the original publication by Vincent et al (17 (link)).
Publication 2009
Arteries Blood Gas Analysis Cells Chest Clinical Protocols Emergencies Ethics Committees, Research Homo sapiens Infection Inpatient Lactates Leukocyte Count Operative Surgical Procedures Patients Physicians Rate, Heart Respiratory Rate Resuscitation Saturation of Peripheral Oxygen Septicemia Serum Severe Sepsis Systemic Inflammatory Response Syndrome Systolic Pressure Venous Catheter, Central
Data are presented as median and range. Grouping of the variables age, tumour type, performance status (ECOG), haemoglobin, white cell count and albumin was carried out using standard thresholds (Paesmans et al, 1997; Herndon et al, 1999 (link)). C-reactive protein concentrations were also grouped (⩽10/>10 mg l−l) as previously described (O'Gorman et al, 2000 (link)). Prognostic scores were constructed by assigning one point for each of the following criteria: stage IV, ECOG 2–4, albumin <35 g l−l and C-reactive protein >10 mg l−l. Cumulative scores were obtained by combining C-reactive protein with each of the other variables.
Univariate survival analysis was performed using the Kaplan–Meier method. Multivariate survival analysis and calculation of hazard ratios (HR) were performed using the Cox regression analysis with prognostic scores as covariates. Deaths up to 31 January 2003 were included in the analysis. Analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA).
Full text: Click here
Publication 2003
Albumins C Reactive Protein Electrocorticography Hemoglobin Leukocyte Count Neoplasms
Blood specimens were rocked for 5 minutes before a white blood cell (WBC) count was measured using the Hemocue white blood cell system (HemoCue, Sweden). Based upon the WBC count, a volume of blood was subjected to erythrocyte lysis (ammonium chloride solution). After centrifugation, nucleated cells were re-suspended in PBS and attached as a monolayer on custom made glass slides. The glass slides are the same size as standard microscopy slides but have a proprietary coating that allows maximal retention of live cells. Each slide can hold approximately 3 million nucleated cells, thus the number of cells plated per slide depended on the patients WBC count.
For HD-CTC detection in cancer patients for this study, 4 slides are used as a test. The remaining slides created for each patient are stored at −80°C for future experiments. Four slides were thawed from each patient, then cells were fixed with 2% paraformaldehyde, permeabilized with cold methanol, and non-specific binding sites were blocked with goat serum. Slides were subsequently incubated with monoclonal anti-pan cytokeratin antibody (Sigma) and CD45-Alexa 647 (Serotec) for 40 minutes at 37°C. After PBS washes, slides were incubated with Alexa Fluor 555 goat anti-mouse antibody (Invitrogen) for 20 minutes at 37°C. Cells were counterstained with DAPI for 10 minutes and mounted with an aqueous mounting media.
Publication 2012
Alexa Fluor 555 Antibodies, Anti-Idiotypic Binding Sites BLOOD Blood Volume Cells Centrifugation Chloride, Ammonium Common Cold Cytokeratin DAPI Erythrocytes Goat Leukocyte Count Leukocytes Malignant Neoplasms Methanol Microscopy Monoclonal Antibodies Mus paraform Patients Retention (Psychology) Serum

Most recents protocols related to «Leukocyte Count»

All patients admitted to our hospital received a basic oral health check, including OHAT, by a dental hygienist to identify those requiring dental treatment and oral care. OHAT was developed for regular oral assessment and protocolisation of oral care, in an attempt to provide equitable, high-quality oral care, regardless of the personnel administering care4 (link) and for objective assessment of the oral environment in clinical practice.
Patients with swallowing dysfunction are commonly referred to the Ear, Nose and Throat department for VE and VF, followed by treatment and rehabilitation.
This study included 24 patients (7 men and 17 women; age range: 64–97 years; average age: 86 years) who were examined by OHAT, VE and VF at Fukuoka Dental College Hospital between April 2014 and October 2019. Patients with head and neck cancers were excluded from the study, as these conditions may affect the oral environment.
A flow chart of patient selection is shown in Figure 1.

Flow chart of patient selection.

A diagnosis of pneumonia was made in cases fulfilling the following criteria: chest X-ray or chest computed tomography (CT) showing an alveolar infiltration shadow, with a fever of 37.5°C or higher and an abnormally high C-reactive protein level, a peripheral white blood cell count of more than 9000/µL and/or the presence of any two or more airway symptoms, such as sputum. We evaluated the associations of the OHAT score with VE and VF and compared the associations between patients with no or only a single episode of pneumonia (no/single-pneumonia episode group) and patients with multiple pneumonia episodes (multiple-pneumonia episode group).
Publication 2023
Cancer of Head and Neck Chest C Reactive Protein Dental Care Dental Health Services Diagnosis Fever Hygienist, Dental Leukocyte Count Nose Patients Pharynx Pneumonia Quality of Health Care Radiography, Thoracic Rehabilitation Sputum Woman X-Ray Computed Tomography
The following coagulation assays (reagent and unit in parenthesis) in citrated (3.2%) plasma were analyzed at the local Central Coagulation Laboratory (HUSLAB of Helsinki University Hospital): FVIII (FVIII:C one-stage clotting assay [IU/dl], pathromtin SL and FVIII deficient plasma), fibrinogen (Clauss method [g/l], HemosIL Q.F.A.Thrombin, Werfen, Barcelona, Spain; D-dimer [mg/l] HemosIL D-Dimer HS 500), antithrombin (AT [%], a chromogenic assay Berichrom Antithrombin III), thrombin time ([s], BC Thrombin reagent, Siemens), activated partial thromboplastin time (APTT [s], Actin FSL®, Siemens) and anti-FXa activity (anti-FXa [IU/ml], HemosIL Liquis Anti-Xa, Mediq Suomi Oy). We acquired data of these coagulation markers preoperatively and from the days 1, 2, 3, 7, 14, 30, 90, and 12 months after the operation, if available.
In addition, we measured the dynamics of white blood cell (WBC) count, C-reactive protein (CRP, mg/l), and platelet count (109/l) from the same time points. Preoperative plasma values of prothrombin time (Medirox Owren's PT [%] Medirox, Nyköping, Sweden), FXIII (F-XIII, %), VWF antigen (VWF:Ag, %) and VWF glycoprotein GPIb binding activity (VWF:Act, %), homocysteine (Hcyst, µmol/l), low-density lipoprotein (mmol/l), and triglycerides (Trigly, mmol/l) were collected. Additionally, patients were screened for protein C and S deficiencies, antiphospholipid antibodies as well as Factor V Leiden and FII G20210A mutations.
Full text: Click here
Publication 2023
Actins Activated Partial Thromboplastin Time Antigens Antiphospholipid Antibodies Antithrombin III azo rubin S Biological Assay Coagulation, Blood C Reactive Protein factor V Leiden fibrin fragment D Fibrinogen Glycoproteins Heparin, Low-Molecular-Weight Homocysteine Leukocyte Count Low-Density Lipoproteins Mutation Patients Plasma Platelet Counts, Blood Protein C Tests, Blood Coagulation Thrombin Times, Prothrombin Times, Reptilase Triglycerides
The CII was defined as the ratio of white blood cell (WBC) count (×109/L) to lymphocyte proportion (%). The optimal threshold of CII was calculated using the X-tile software (Version 3.6.1, Yale University, New Haven, CT). Ultimately, 43.1 was determined as the optimal cutoff value of CII in the training cohort and was used to stratify patients in subsequent analyses.
Full text: Click here
Publication 2023
Leukocyte Count Lymphocyte Patients
Descriptive statistics were used to present the patients’ characteristics and clinical parameters with mean ± standard deviation or frequency. The chi-square test was employed for frequency data, presented as n and %.
The threshold for anemia was hemoglobin < 12 g/dl in female patients and < 13 g/dl in male patients. ID was defined by the threshold for ferritin as < 30 ng/ml with normal levels of CRP and ferritin < 100 ng/ml with CRP levels > 5 mg/l. The reference cutoffs were based on reference ranges that were either previously established by clinical research or taken from the local laboratory.
The relevance for survival was investigated for clinical parameters associated with outcome in SSc including sex, age, type of SSc, presence of ILD [15 (link)], DLCO ≤ 65% predicted [5 (link)], and PVR ≥ 2 WU [10 (link)]. Furthermore, parameters associated with iron metabolism or inflammation including CRP and white blood cell count were compared between the groups. The Mann-Whitney U test was employed to compare the clinical characteristics between the patient groups with HRC > 2% and ≤ 2%.
The prognostic values for survival were investigated by uni- and multivariable Cox regression analysis. Death due to any cause, date of lung transplantation, or date of last contact was recorded for survival at follow-up and compared to the time of the first evaluation (baseline). Univariable categorial analysis was performed by Kaplan-Meier analysis. A multivariable Cox model was performed including all variables, which were significantly associated with survival (p < 0.05) in the univariable log rank tests. The combined independent parameters for risk assessment were compared with known risk stratification tools REVEAL [16 (link)], REVEAL 2.0 [17 (link)], COMPERA [18 ], and the French risk assessment strategy [19 ]. p-values < 0.05 were considered as statistically significant. IBM SPSS V 27.0 was used to conduct all analyses (IBM Corp. Released 2020. IBM SPSS Statistics for Macintosh, version 27.0. Armonk, NY: IBM Corp.).
Full text: Click here
Publication 2023
Anemia Ferritin Health Risk Assessment Hemoglobin Inflammation Iron Leukocyte Count Lung Transplantation Males Metabolism Patients Woman
Preoperative factors were collected, including age, sex, recent major cardiovascular procedure (within 3 months), coronary artery disease, cerebral vascular events, chronic lung disease, essential hypertension, dyslipidemia, liver cirrhosis, atrial fibrillation, type 2 diabetes mellitus, end-stage renal disease with dialysis (both hemodialysis and peritoneal dialysis), and regular use of antiplatelet or anticoagulant agents. The major cardiovascular procedures included coronary arterial bypass, coronary arterial angioplasty/stenting, cardiac valvular surgery, aortic surgery, and peripheral arterial surgery. Preoperative blood cell counts included white cell counts, differential counts (immature band form white cell) [15 (link)], platelet counts, the neutrophil-to-lymphocyte ratio (NLR) [16 (link)], and hemoglobin levels. Preoperative blood biochemistry results included serum levels of albumin, alanine aminotransferase (ALT), bilirubin, and creatinine. The coagulation test included the prothrombin time (PT) and was expressed by the international normalized ratio (INR). Preoperative shock status was defined as the requirement for vasopressors or inotropes. The types of AMI were determined by preoperative contrast CT scans.
Full text: Click here
Publication 2023
Angioplasty Angioplasty, Balloon, Coronary Anticoagulants Aorta Arteries Artery, Coronary Atrial Fibrillation Bilirubin BLOOD Cardiovascular System Cells Cerebrovascular Accident Coronary Arteriosclerosis Coronary Artery Bypass Surgery Creatinine D-Alanine Transaminase Diabetes Mellitus, Non-Insulin-Dependent Dialysis Disease, Chronic Dyslipidemias Essential Hypertension Hemodialysis Hemoglobin Inotropism International Normalized Ratio Kidney Failure, Chronic Leukocyte Count Liver Cirrhosis Lung Lung Diseases Lymphocyte Neutrophil Neutrophil Band Cells Operative Surgical Procedures Peritoneal Dialysis Platelet Counts, Blood Serum Albumin Shock Surgical Procedure, Cardiac Tests, Blood Coagulation Times, Prothrombin Vasoconstrictor Agents X-Ray Computed Tomography

Top products related to «Leukocyte Count»

Sourced in Japan, Germany, United Kingdom, United States, Brazil
The XE-2100 is a hematology analyzer designed for automated blood cell analysis. It provides comprehensive analysis of various blood cell types, including red blood cells, white blood cells, and platelets. The XE-2100 is capable of performing a wide range of hematological tests and measurements to support clinical decision-making.
Sourced in Japan, Germany, United States, China, Portugal, Denmark
The XE-5000 is a fully automated hematology analyzer developed by Sysmex. The XE-5000 is designed to perform complete blood count (CBC) and white blood cell differential analysis on biological samples.
Sourced in United States, Germany, United Kingdom, China, Canada, Japan, Italy, France, Belgium, Switzerland, Singapore, Uruguay, Australia, Spain, Poland, India, Austria, Denmark, Netherlands, Jersey, Finland, Sweden
The FACSCalibur is a flow cytometry system designed for multi-parameter analysis of cells and other particles. It features a blue (488 nm) and a red (635 nm) laser for excitation of fluorescent dyes. The instrument is capable of detecting forward scatter, side scatter, and up to four fluorescent parameters simultaneously.
Sourced in United States
The Biochemistry Panel Plus analyzer discs by Abaxis are designed for clinical laboratory use to perform quantitative analysis of various analytes in biological samples. The discs provide a compact and integrated platform for automated processing and testing.
Sourced in United States, Germany, United Kingdom, Belgium, China, Australia, France, Japan, Italy, Spain, Switzerland, Canada, Uruguay, Netherlands, Czechia, Jersey, Brazil, Denmark, Singapore, Austria, India, Panama
The FACSCanto II is a flow cytometer instrument designed for multi-parameter analysis of single cells. It features a solid-state diode laser and up to four fluorescence detectors for simultaneous measurement of multiple cellular parameters.
Sourced in United States
The Hemavet 950 is a compact, automated hematology analyzer designed for comprehensive blood cell analysis. It provides accurate and reliable measurements of various blood parameters, including red blood cells, white blood cells, and platelet counts.
Sourced in Japan, Germany, United States, France, Switzerland, China
The XN-9000 is a hematology analyzer manufactured by Sysmex. It is designed to perform complete blood count (CBC) analysis, including the determination of red blood cells, white blood cells, and platelets. The XN-9000 utilizes advanced technology to provide accurate and reliable results.
Sourced in China, Germany, United States
The BC-2800Vet is a compact, automated hematology analyzer designed for veterinary use. It provides a comprehensive analysis of blood samples, including complete blood count (CBC) parameters.
Sourced in United States, Germany, United Kingdom, France, Canada, Belgium, Australia, Italy, Spain, Switzerland, China, Netherlands, Finland, Japan, Jersey, Lao People's Democratic Republic
FACSDiva software is a user-friendly flow cytometry analysis and data management platform. It provides intuitive tools for data acquisition, analysis, and reporting. The software enables researchers to efficiently process and interpret flow cytometry data.
Sourced in Japan, Germany, United States, India
The KX-21 is a compact, automated hematology analyzer designed for routine blood cell analysis. It provides a rapid and accurate assessment of common blood parameters, including red blood cell count, white blood cell count, and platelet count.

More about "Leukocyte Count"